Literature DB >> 21292834

Eplerenone suppresses aldosterone/ salt-induced expression of NOX-4.

Mohamed A Bayorh1, Aisha Rollins-Hairston, Jeffery Adiyiah, Deborah Lyn, Danita Eatman.   

Abstract

INTRODUCTION: Salt-induced hypertension in the Dahl rat is associated with increases in angiotensin II, aldosterone, free radical generation and endothelial dysfunction. However, little is known about the specific mechanism(s) associated with the end-organ damage effects of aldosterone. We hypothesised that eplerenone reduces kidney damage by blocking nicotinamide adenine dinucleotide phosphate (NADPH) oxidase activity.
METHODS: Dahl salt-sensitive rats fed either a low-salt (LS) or high-salt (HS) diet were treated with aldosterone in the presence of eplerenone or apocynin. Indirect blood pressure was measured prior to start of diet and weekly thereafter. Levels of plasma nitric oxide (NO) and urinary 8-isoprostane were measured following treatment. Protein levels of selected subunits of NADPH were assessed by western blot.
RESULTS: Eplerenone and apocynin inhibited the rise in blood pressure induced by HS and/or aldosterone. This observation was accompanied with a parallel change in kidney protein levels of NADPH oxidase 4 (NOX-4) and p22phox. Aldosterone and high salt were associated with lower NO levels and greater renal oxidative stress.
CONCLUSIONS: NADPH oxidase is associated with the vascular and renal remodelling observed in high dietary salt intake. Aldosterone-induced expression of NOX-4 plays a pivotal role in the end-organ damage effect of aldosterone, as eplerenone tended to reduce kidney damage and inhibit NOX expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21292834      PMCID: PMC3351030          DOI: 10.1177/1470320310391330

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  23 in total

1.  A novel superoxide-producing NAD(P)H oxidase in kidney.

Authors:  A Shiose; J Kuroda; K Tsuruya; M Hirai; H Hirakata; S Naito; M Hattori; Y Sakaki; H Sumimoto
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Aldosterone-induced inflammation in the rat heart : role of oxidative stress.

Authors:  Yao Sun; Jiakun Zhang; Li Lu; Sue S Chen; Mark T Quinn; Karl T Weber
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Altered aldosterone response to salt intake and angiotensin II infusion in young normotensive men with parental history of arterial hypertension.

Authors:  Markus P Schlaich; Arnfried U Klingbeil; Johannes Jacobi; Christian Delles; Markus P Schneider; Bernhard M W Schmidt; Roland E Schmieder
Journal:  J Hypertens       Date:  2002-01       Impact factor: 4.844

4.  Mineralocorticoid receptor antagonism in experimental atherosclerosis.

Authors:  Sanjay Rajagopalan; Damon Duquaine; Steven King; Bertram Pitt; Paresh Patel
Journal:  Circulation       Date:  2002-05-07       Impact factor: 29.690

Review 5.  Aldosterone and progression of kidney disease.

Authors:  Monica Cortinovis; Norberto Perico; Dario Cattaneo; Giuseppe Remuzzi
Journal:  Ther Adv Cardiovasc Dis       Date:  2009-01-26

6.  Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent.

Authors:  Karen A Griffin; Isam Abu-Amarah; Maria Picken; Anil K Bidani
Journal:  Hypertension       Date:  2003-02       Impact factor: 10.190

7.  Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

Authors:  Ricardo Rocha; Cynthia L Martin-Berger; Pochang Yang; Rachel Scherrer; John Delyani; Ellen McMahon
Journal:  Endocrinology       Date:  2002-12       Impact factor: 4.736

8.  Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats.

Authors:  Mohamed A Bayorh; Agaba A Ganafa; Robin R Socci; Danita Eatman; Natalia Silvestrov; Imad K Abukhalaf
Journal:  Am J Hypertens       Date:  2003-05       Impact factor: 2.689

9.  Spironolactone improves angiotensin-induced vascular changes and oxidative stress.

Authors:  Agostino Virdis; Mario Fritsch Neves; Farhad Amiri; Emilie Viel; Rhian M Touyz; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2002-10       Impact factor: 10.190

10.  Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats.

Authors:  Shumei Meng; L Jackson Roberts; Garrick W Cason; Travis S Curry; R Davis Manning
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-09       Impact factor: 3.619

View more
  16 in total

1.  PVN adenovirus-siRNA injections silencing either NOX2 or NOX4 attenuate aldosterone/NaCl-induced hypertension in mice.

Authors:  Baojian Xue; Terry G Beltz; Ralph F Johnson; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-02       Impact factor: 4.733

Review 2.  Targeting NADPH oxidases in vascular pharmacology.

Authors:  Agata Schramm; Paweł Matusik; Grzegorz Osmenda; Tomasz J Guzik
Journal:  Vascul Pharmacol       Date:  2012-03-03       Impact factor: 5.773

Review 3.  Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.

Authors:  Fadia Mayyas; Karem H Alzoubi; David R Van Wagoner
Journal:  Int J Cardiol       Date:  2013-08-15       Impact factor: 4.164

4.  The sodium-activated sodium channel is expressed in the rat kidney thick ascending limb and collecting duct cells and is upregulated during high salt intake.

Authors:  Lucienne S Lara; Ryousuke Satou; Camille R T Bourgeois; Alexis A Gonzalez; Andrea Zsombok; Minolfa C Prieto; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2012-03-21

5.  Eplerenone inhibits aldosterone-induced renal expression of cyclooxygenase.

Authors:  Ma Bayorh; A Rollins-Hairston; J Adiyiah; D Lyn; D Eatman
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-05-03       Impact factor: 1.636

Review 6.  Oxidative stress in hypertension: role of the kidney.

Authors:  Magali Araujo; Christopher S Wilcox
Journal:  Antioxid Redox Signal       Date:  2013-04-30       Impact factor: 8.401

7.  Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice.

Authors:  Yu-qiong Li; Xiao-bo Li; Shu-jie Guo; Shao-li Chu; Ping-jin Gao; Ding-liang Zhu; Wen-quan Niu; Nan Jia
Journal:  Acta Pharmacol Sin       Date:  2013-01-21       Impact factor: 6.150

8.  Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.

Authors:  Jacqueline N Minas; Max A Thorwald; Debra Conte; Jose-Pablo Vázquez-Medina; Akira Nishiyama; Rudy M Ortiz
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-11       Impact factor: 2.557

Review 9.  The Role of the Mineralocorticoid Receptor in Inflammation: Focus on Kidney and Vasculature.

Authors:  Zachary Belden; Jeffrey A Deiuliis; Mirela Dobre; Sanjay Rajagopalan
Journal:  Am J Nephrol       Date:  2017-10-10       Impact factor: 3.754

Review 10.  Aldosterone affects blood flow and vascular tone regulated by endothelium-derived NO: therapeutic implications.

Authors:  Noboru Toda; Sadanobu Nakanishi; Shinichi Tanabe
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.